Qualitative Platelet 12-Lipoxygenase Abnormality in a Patient with Essential Thrombocythemia

Summary

Quantitative platelet 12-lipoxygenase (12-LOX) deficiency has been reported in some patients with myeloproliferative disorders (MPD). We report here for the first time a novel qualitative abnormality of the 12-LOX enzyme of platelets from a patient with essential thrombocythemia. The anti-12-LOX immunoprecipitates from the patient’s platelet homogenates showed a deficiency of 12-LOX activity, but contained normal amount of 12-LOX protein. There was no difference in subcellular localization of the enzyme between the patient’s platelets and normal ones. This 12-LOX protein lacking its enzyme activity showed slightly larger electrophoretic mobility than normal one, suggesting a molecular abnormality of the enzyme. However, we could not detect any genetic mutation causing such abnormalities in all exons of 12-LOX gene by sequencing the patient’s PCR-amplified DNA. Thus, our results indicate that the deficient activity of this abnormal 12-LOX protein is probably due to a posttranslational modification, and the possibility that platelets of some MPD patients have qualitative abnormality of the 12-LOX enzyme besides quantitative one.

• References

• 1 Brash AR. A review of possible roles of the platelet 12-lipoxygenase. Circulation 1985; 72: 702-707
• 2 Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1992; 1128: 117-131
• 3 Okuma M. Qualitative platelet abnormalities in myeloproliferative disorders. Thromb Haemorrh Disord 1992; 06: 29-39
• 4 Okuma M, Uchino H. Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. Blood 1979; 54: 1258-1271
• 5 Schafer AI. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders. N Engl J Med 1982; 306: 381-386
• 6 Stenke L, Edenius C, Samuelsson J, Lindgren JA. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2989-2995
• 7 Matsuda S, Yamamoto S, Okuma M. Decreased messenger RNA of arachidonate 12-lipoxygenase in platelets of patients with myeloproliferative disorders. Biochim Biophys Acta 1993; 1180: 243-249
• 8 Kanaji K, Okuma M, Ushikubi F, Uchino H. Lipoxygenase activities of human platelets and their subcellular fractions: comparison between lipoxygenase-deficient platelets and normal platelets. Prostagland Leuk Essent Fatty 1988; 31: 155-161
• 9 Takahashi Y, Ueda N, Yamamoto S. Two immunologically and catalytically distinct arachidonate 12-lipoxygenases of bovine platelets and leukocytes. Arch Biochem Biophys 1988; 266: 613-621
• 10 Nakamura M, Ueda N, Kishimoto K, Yoshimoto T, Yamamoto S. Immuno-cytochemical localization of platelet-type arachidonate 12-lipoxygenase in mouse blood cells. J Histochem Cytochem 1995; 43: 237-244
• 11 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
• 12 Marchuk D, Drumm M, Saulino A, Collins FS. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 1991; 19: 1154
• 13 Yoshimoto T, Arakawa T, Hada T, Yamamoto S, Takahashi E. Structure and Chromosomal Localization of Human Arachidonate 12-Lipoxygenase Gene. J Biol Chem 1992; 267: 24805-24809
• 14 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
• 15 Funk CD, Furci L, Fitzgerald GA. Molecular cloning of the human platelet lipoxygenase. Proc Natl Acad Sci USA 1990; 87: 5638-5642
• 16 Yoshimoto T, Yamamoto Y, Arakawa T, Suzuki H, Yamamoto S, Yokoyama C, Tanabe T, Toh H. Molecular cloning and expression of human arachidonate 12-lipoxygenase. Biochem Biophys Res Commun 1990; 172: 1230-1235
• 17 Izumi T, Hoshiko S, Radmark O, Samuelsson B. Cloning of the cDNA for human 12-lipoxygenase. Proc Natl Acad Sci USA 1990; 87: 7477-7481